The tobacco industry spent decades persuading the world that cigarettes were sophisticated, harmless, and even medically beneficial. By the time the scientific consensus was undeniable, millions had died. Today, the same playbook is being used to promote vaping and e-cigarettes — "safer than cigarettes," "just water vapor," "a healthy alternative." The evidence tells a different, far more concerning story.
Tobacco and nicotine product use is the leading preventable cause of death globally. In the Philippines, smoking kills an estimated 111 Filipinos every day — approximately 40,000 deaths per year. As traditional cigarette rates have slowly declined, vaping has exploded — particularly among young Filipinos who have never smoked cigarettes and are now inhaling nicotine and chemical aerosols with unknown long-term consequences.
Tobacco Use in the Philippines: Understanding the Scale
According to the 2021 Philippine Global Adult Tobacco Survey (GATS), approximately 19% of Filipino adults use some form of tobacco — translating to roughly 17 million smokers. Despite being lower than historical rates, this remains extraordinarily high in absolute numbers. Males smoke at far higher rates (36%) than females (4%), though female rates are rising.
The Philippines has implemented significant tobacco control policies including graphic health warnings, public smoking bans, and advertising restrictions. However, tobacco products remain extremely affordable relative to income, and enforcement of smoke-free rules is inconsistent. Additionally, the rapid rise of vaping represents a new and urgent front in the tobacco control effort.
What Cigarettes Actually Do to Your Body
Cigarette smoke contains over 7,000 chemicals. At least 250 are known to be harmful; 69 are known carcinogens (cancer-causing agents). The damage is systemic — it affects virtually every organ system in the body.
Lung and Respiratory System
The most direct damage occurs in the lungs. Chronic obstructive pulmonary disease (COPD) — including emphysema and chronic bronchitis — occurs in 15–20% of long-term smokers and is the third leading cause of death in the Philippines. COPD causes progressive, irreversible destruction of lung tissue and airways. Symptoms include persistent cough, increasing breathlessness, and frequent respiratory infections. By the time most patients are diagnosed, they have already lost 50% of their lung function.
Lung cancer is almost entirely a smoking-related disease: 85% of lung cancer cases are attributable to tobacco use. Smoking also increases risk of cancers of the throat, larynx, esophagus, stomach, pancreas, kidney, bladder, and cervix. The risk of lung cancer in a person who has smoked for 40 years is 30–40 times higher than in a non-smoker.
Cardiovascular System
Smoking doubles the risk of heart attack. It is a major independent risk factor for stroke, peripheral artery disease, and aortic aneurysm. Nicotine itself causes immediate cardiovascular effects: increased heart rate, elevated blood pressure, arterial constriction, and increased thrombosis (blood clot) risk. The toxic chemicals in smoke cause direct damage to the inner lining of blood vessels (endothelium), accelerating atherosclerosis throughout the body.
The One-in-Two Reality
The most sobering statistic about long-term smoking: approximately 1 in 2 long-term smokers will die from a smoking-related illness. This is not a small or uncertain risk — it is the largest individual risk factor for preventable premature death identified in medicine.
Vaping: Separating Myths from Facts
E-cigarettes and vaping devices have been marketed aggressively in the Philippines and globally with claims that consistently outpace the evidence. Here is a direct factual assessment of the most common claims:
E-cigarette aerosol is not water vapor. It contains fine and ultrafine particles, nicotine, volatile organic compounds (VOCs), heavy metals including lead and nickel from heating coils, and flavoring chemicals — many of which are toxic when inhaled. Diacetyl, a butter-flavoring compound found in many vape flavors, causes a severe, irreversible lung condition called bronchiolitis obliterans ("popcorn lung").
E-cigarette aerosol contains a complex mixture of potentially harmful chemicals, though generally at lower concentrations than cigarette smoke.
While e-cigarettes don't produce tar (a byproduct of tobacco combustion), the absence of tar does not make them safe. The harm from vaping comes from nicotine, fine particulate matter, and aerosol chemicals — not only from tar.
E-cigarettes are probably less harmful than combustible cigarettes for current adult smokers switching completely — but they are not safe, and certainly not safe for people who have never smoked.
The evidence on vaping as a cessation tool is mixed and concerning. While some smokers do switch completely to vaping, the majority of people who use e-cigarettes to quit end up as dual users — using both cigarettes and vapes — which may actually increase total nicotine and chemical exposure. Regulated nicotine replacement therapies (patches, gum, lozenges) combined with behavioral support have stronger evidence for successful cessation.
Cessation medications (varenicline, bupropion) and nicotine replacement therapy (NRT) have the strongest evidence for smoking cessation. Vaping should not be recommended as a first-line cessation strategy.
Nicotine salt formulations used in pod-style devices like JUUL, Vuse, and similar products deliver nicotine at extremely high concentrations — up to 50–60 mg/mL — making them far more addictive than standard freebase nicotine vapes or cigarettes. A single pod can contain as much nicotine as a full pack of cigarettes.
High-nicotine pod mods create extremely rapid, strong nicotine dependence — particularly in young people whose dopamine systems are still developing.
EVALI: Vaping-Related Lung Disease
E-cigarette or Vaping-Associated Lung Injury (EVALI) became a major global health concern in 2019 when a sudden outbreak of severe lung disease — including deaths — was linked to vaping. EVALI causes acute respiratory distress, fever, cough, and chest pain that can rapidly progress to respiratory failure requiring intensive care.
While vitamin E acetate (used in some counterfeit cannabis vaping products) was identified as a major culprit in the initial outbreak, ongoing research has identified lung injury from a wide range of vaping aerosol components. Cases continue to be reported globally. In the Philippines, where vaping product regulation and quality control are inconsistent and counterfeit products are widely available, the risk of EVALI and other vaping-related lung injuries is particularly elevated.
The Youth Vaping Epidemic in the Philippines
The most alarming dimension of the vaping crisis in the Philippines is its demographics. While traditional cigarette use is concentrated in older Filipinos, vaping has found its primary market among young people — students in high school, college, and even middle school.
A 2022 Department of Health survey found that e-cigarette use among Filipino youth aged 15–24 had increased significantly, with many using disposable vapes with high-nicotine pod formulations. Marketing of vaping products on TikTok, Instagram, and Facebook, often by youth influencers, promotes the products as cool, flavored, and harmless. Flavors like mango, bubblegum, and candy are explicitly designed to appeal to young people.
The public health consequences are severe:
- Nicotine addiction in adolescence: The adolescent brain is significantly more vulnerable to nicotine addiction than the adult brain. Teens who vape become addicted more rapidly, with more severe dependence, than adults who start smoking. Nicotine addiction in adolescence is linked to lasting changes in brain development affecting attention, impulse control, and mood.
- Gateway to cigarettes: Multiple studies show that adolescents who vape are significantly more likely to subsequently start smoking cigarettes — the reverse of what the "harm reduction" narrative suggested.
- Unknown long-term consequences: We do not yet know the full long-term health consequences of vaping in youth, because the first generation of adolescent vapers has only been vaping for approximately a decade. The full picture of lung disease, cardiovascular effects, and cancer risk will emerge over the next 20–30 years.
Secondhand and Thirdhand Smoke
The harm from tobacco is not limited to smokers. Secondhand smoke — the smoke exhaled by a smoker and the smoke from the burning end of a cigarette — contains the same toxic chemicals as inhaled smoke. Exposure to secondhand smoke causes lung cancer, heart disease, and stroke in non-smokers. It is particularly dangerous for children, causing sudden infant death syndrome (SIDS), low birth weight, asthma, ear infections, and impaired lung development.
Thirdhand smoke refers to the residue — the chemical compounds from tobacco smoke that settle on surfaces, fabrics, hair, and skin after smoking. This residue can remain for months and is absorbed through skin contact, ingested by crawling infants, and re-released into air. Children in households where smoking occurs indoors are exposed to thirdhand smoke long after any visible smoke has dissipated.
There is no safe level of secondhand smoke exposure. Smoking outdoors, by an open window, or under a ventilator fan does not eliminate exposure risk for household members — only complete smoke-free environments protect non-smokers.
| Risk Factor | Cigarette Smoking | E-Cigarette / Vaping |
|---|---|---|
| Lung cancer risk | 30–40x increased (long-term) | Unknown; likely increased |
| COPD risk | 15–20% of long-term smokers | Increased; extent unclear |
| Cardiovascular risk | 2x heart attack risk | Elevated; cardiovascular effects confirmed |
| Nicotine addiction | High — 1/3 of first-time users become dependent | Very high (pod mods) to high; faster addiction in youth |
| Acute lung injury risk | Low for acute events; chronic damage universal | EVALI risk, especially from unregulated products |
| Secondhand harm | Confirmed; significant risk to non-smokers | Aerosol contains harmful compounds; lower than cigarettes |
| Youth targeting | Declining; restrictions more enforced | Active, aggressive; flavors designed for youth appeal |
Quitting: Every Attempt Matters
Quitting smoking is one of the hardest things a person can do — nicotine is among the most addictive substances known. Withdrawal symptoms (irritability, anxiety, difficulty concentrating, insomnia, intense cravings) typically peak in the first 2–5 days and gradually subside over 2–4 weeks, though cravings can recur for months.
The most important thing to know about quitting is this: most successful quitters needed multiple attempts before succeeding. Each failed attempt is not a personal failure — it is a learning experience. Every attempt increases the likelihood of eventual success. You are never "past the point" of benefiting from quitting.
Evidence-Based Quitting Strategies
- Varenicline (Champix): Prescription medication that reduces cravings and the reward from smoking. Most effective pharmacotherapy for smoking cessation — increases quit rates by 2–3x compared to placebo. Requires prescription and physician supervision.
- Nicotine replacement therapy (NRT): Patches, gum, lozenges, or inhalers that provide nicotine without tobacco toxins, reducing withdrawal symptoms while breaking the habit. Available over the counter. Combining two forms of NRT (e.g., patch + gum) is more effective than either alone.
- Bupropion (Wellbutrin): Antidepressant medication with proven efficacy for smoking cessation, especially for smokers with concurrent depression.
- Behavioral support: Counseling, support groups, and quitline support significantly increase success rates. Combined with pharmacotherapy, the success rate is substantially higher than either alone.
- Setting a quit date: Choosing a specific date and telling people about your decision increases accountability and success rate.
Benefits of Quitting — Timeline
- 20 minutes: Heart rate and blood pressure begin to drop
- 12 hours: Carbon monoxide in blood drops to normal; oxygen levels normalize
- 48 hours: Sense of taste and smell begin to recover
- 2 weeks–3 months: Lung function and circulation improve; coughing and breathlessness decrease
- 1 year: Risk of coronary heart disease is halved compared to a smoker
- 5 years: Stroke risk reduced to that of a non-smoker
- 10 years: Lung cancer risk halved; cancer risk in other organs decreasing
- 15 years: Heart disease risk similar to someone who has never smoked
Pulmonology and Respiratory Care at Chong Hua Hospital
Chong Hua Hospital's Department of Pulmonology provides comprehensive care for tobacco-related respiratory diseases including COPD, lung cancer diagnosis and management, asthma, and smoking-related lung disease. Our pulmonologists also provide smoking cessation consultations and can prescribe evidence-based cessation pharmacotherapy.
If you are a current smoker or vaper experiencing respiratory symptoms — persistent cough, breathlessness, frequent chest infections, or coughing blood — do not wait. Early diagnosis of COPD and tobacco-related lung disease dramatically changes the treatment options available and the outcomes achievable.
For parents concerned about teen vaping, our Pulmonology and Psychiatry departments can provide assessment and guidance. For young people experiencing symptoms from vaping, our Emergency Department is available 24/7 — please be honest with medical staff about vaping use for the most accurate diagnosis and care.